https://www.viricabiotech.com/resources/virica-brochure/2025-11-03T21:16:19-05:00https://www.viricabiotech.com/resources/antiviral-defenses-what-you-need-to-know/2025-06-19T14:35:09-04:00https://www.viricabiotech.com/resources/closing-the-gaps-in-cell-gene-therapy-manufacturing-with-bioprocess-modelling/2025-06-19T14:35:50-04:00https://www.viricabiotech.com/resources/sustainability-savings-in-vaccine-manufacturing-with-bioprocess-modelling/2025-06-27T13:15:42-04:00https://www.viricabiotech.com/resources/modeling-benefits-of-viral-sensitizers-to-increase-virus-production/2025-04-29T20:19:32-04:00https://www.viricabiotech.com/resources/increasing-vaccine-production-yields-using-small-molecules/2025-04-29T20:18:42-04:00https://www.viricabiotech.com/resources/development-and-scale-up-validation-of-small-molecule-viral-sensitizers-for-increased-vaccine-manufacturing-yields/2025-10-02T11:18:07-04:00https://www.viricabiotech.com/resources/bioprocess-modelling-of-upstream-viral-vector-production/2025-04-29T20:18:10-04:00https://www.viricabiotech.com/resources/a-novel-approach-to-enhancing-viral-vector-manufacturing-using-small-molecules/2025-04-29T20:17:43-04:00https://www.viricabiotech.com/resources/increase-viral-vector-yield-small-molecule-enhancers-validation-at-multiple-scales/2025-04-29T20:17:16-04:00https://www.viricabiotech.com/resources/the-impacts-of-suppressing-cellular-innate-immune-responses-on-aav-yields-during-production/2025-04-29T20:16:47-04:00https://www.viricabiotech.com/resources/increased-viral-vector-yield-development-and-scale-up-validation-of-small-molecule-enhancers/2025-04-29T20:16:18-04:00https://www.viricabiotech.com/resources/harnessing-the-power-of-high-throughput-virology-and-doe-for-rapid-vector-optimization/2025-04-29T20:15:49-04:00https://www.viricabiotech.com/resources/evaluation-of-small-molecule-antagonists-of-cellular-innate-immunity-for-t-cell-manufacturing/2025-04-29T20:15:19-04:00https://www.viricabiotech.com/resources/viral-sensitizers-unleash-host-cell-potential-to-enhance-aav-production/2025-04-29T20:14:42-04:00https://www.viricabiotech.com/resources/increased-aav-yield-from-screen-to-scale-up-to-cost-savings-using-viral-sensitizers-vse-technology/2025-04-29T20:14:15-04:00https://www.viricabiotech.com/resources/the-impact-of-antiviral-defenses-in-viral-vector-production/2025-04-29T20:13:57-04:00https://www.viricabiotech.com/resources/pfizer-paper-production-of-raav-by-plasmid-transfection-induces-antiviral-inflammatory-responses-in-suspension-hek293-cells/2025-06-19T14:39:56-04:00https://www.viricabiotech.com/resources/overcoming-the-challenges-of-antiviral-defenses-in-viral-vector-manufacturing/2025-06-19T14:39:22-04:00https://www.viricabiotech.com/resources/harnessing-the-statistical-power-of-design-of-experiments-to-maximize-viral-vector-biomanufacturing-production/2025-06-19T14:38:51-04:00https://www.viricabiotech.com/resources/small-gains-big-wins-how-incremental-yield-increases-drive-major-cost-savings-in-cell-and-gene-therapy-manufacturing/2025-06-19T14:38:14-04:00https://www.viricabiotech.com/resources/increasing-aav8-yields-in-the-icellis-nano-bioreactor-using-vse-technology/2025-04-30T07:55:39-04:00https://www.viricabiotech.com/resources/high-throughput-screening-of-next-generation-small-molecule-enhancers-and-process-automation-in-cloud-connected-bioreactors/2025-05-08T19:07:35-04:00https://www.viricabiotech.com/resources/end-to-end-optimization-of-car-t-manufacturing-boosting-lentiviral-production-and-t-cell-transduction-with-viral-sensitizer-technology/2025-10-04T15:21:29-04:00https://www.viricabiotech.com/resources/optimizing-aav-production-accelerating-discovery-of-small-molecule-enhancers-using-high-throughput-virology-and-design-of-experiments/2025-05-10T14:23:26-04:00https://www.viricabiotech.com/resources/vaccine-vector-production-enhancement-using-small-molecule-vse/2025-06-03T13:15:41-04:00https://www.viricabiotech.com/resources/small-molecule-antagonists-of-cellular-innate-immunity-for-enhanced-cell-and-gene-therapy-manufacturing/2025-06-14T07:39:42-04:00https://www.viricabiotech.com/resources/rapidly-optimizing-viral-vector-production-without-process-disruption/2025-06-19T12:44:03-04:00https://www.viricabiotech.com/resources/the-virica-advantage-rapidly-maximize-viral-yields-and-cut-production-costs/2025-06-23T13:49:12-04:00https://www.viricabiotech.com/resources/maximize-viral-yields-with-viricas-curated-vse-library/2025-06-23T13:48:20-04:00https://www.viricabiotech.com/resources/purpose-built-vses-for-vpc-2-0-and-fectovir-combination-platforms/2025-06-23T13:47:30-04:00https://www.viricabiotech.com/resources/regulatory-and-scale-up-support-with-you-every-step-of-the-journey/2025-06-23T13:46:50-04:00https://www.viricabiotech.com/resources/optimization-of-zika-vaccine-production-using-small-molecule-viral-sensitizers-to-enhance-yields/2025-07-17T07:54:52-04:00https://www.viricabiotech.com/resources/optimizing-aav-production-efficiency-a-scalable-approach-using-small-molecule-viral-sensitizers/2025-10-02T11:14:07-04:00https://www.viricabiotech.com/resources/enhancing-lentiviral-transduction-efficiency-and-reducing-moi-in-therapeutically-relevant-cell-types-using-small-molecule-viral-sensitizers/2025-10-02T11:15:30-04:00https://www.viricabiotech.com/resources/optimizing-aav-production-efficiency-with-cellvantage-aav-a-simple-scalable-approach-for-enhanced-upstream-yield/2026-04-03T11:45:53-04:00